BY 758

Drug Profile

BY 758

Latest Information Update: 02 Apr 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nycomed
  • Class
  • Mechanism of Action Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Gastro-oesophageal reflux; Heartburn

Most Recent Events

  • 02 Apr 2008 Discontinued - Preclinical for Gastro-oesophageal reflux in Germany (PO)
  • 02 Apr 2008 Discontinued - Preclinical for Heartburn in Germany (PO)
  • 09 Jul 2002 Byk Gulden is now called Altana Pharma
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top